Susquehanna International Group, LLP Cassava Sciences Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$9.57 - $35.08 $4.52 Million - $16.6 Million	472,700 Added 170.47%	750,000 $22.1 Million
Q2 2024 Aug 15, 2024	SELL	$12.35 - $26.11 $2.93 Million - $6.19 Million	-237,100 Reduced 46.09%	277,300 $3.42 Million
Q1 2024 May 07, 2024	SELL	$18.44 - $26.41 $4.79 Million - $6.87 Million	-260,000 Reduced 33.57%	514,400 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$12.64 - $30.11 $1.12 Million - $2.67 Million	-88,800 Reduced 10.29%	774,400 $17.4 Million
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $6.88 Million - $10.5 Million	413,300 Added 91.86%	863,200 $14.4 Million
Q2 2023 Aug 11, 2023	SELL	$21.59 - $27.88 $4.19 Million - $5.41 Million	-193,900 Reduced 30.12%	449,900 $11 Million
Q1 2023 May 16, 2023	SELL	$23.46 - $36.44 $6.58 Million - $10.2 Million	-280,500 Reduced 30.35%	643,800 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$27.82 - $44.16 $11.1 Million - $17.6 Million	-398,200 Reduced 30.11%	924,300 $27.3 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $7.09 Million - $22.2 Million	434,000 Added 48.85%	1,322,500 $55.3 Million
Q2 2022 Aug 15, 2022	BUY	$17.22 - $38.47 $1.02 Million - $2.28 Million	59,300 Added 7.15%	888,500 $25 Million
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $6.75 Million - $11 Million	-207,100 Reduced 19.98%	829,200 $30.8 Million
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $9.71 Million - $24 Million	-264,000 Reduced 20.3%	1,036,300 $45.3 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $35.4 Million - $115 Million	846,900 Added 186.79%	1,300,300 $80.7 Million
Q2 2021 Aug 11, 2021	BUY	$32.15 - $89.72 $2.59 Million - $7.22 Million	80,500 Added 21.59%	453,400 $38.7 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $2.33 Million - $29 Million	329,200 Added 753.32%	372,900 $16.8 Million
Q4 2020 Feb 16, 2021	SELL	$6.79 - $12.25 $216,601 - $390,775	-31,900 Reduced 42.2%	43,700 $298,000
Q3 2020 Nov 16, 2020	SELL	$2.86 - $11.51 $157,872 - $635,352	-55,200 Reduced 42.2%	75,600 $870,000
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $86,700 - $409,700	42,500 Added 48.13%	130,800 $403,000
Q1 2020 May 15, 2020	BUY	$3.26 - $9.65 $287,858 - $852,095	88,300 New	88,300 $363,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$85.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$66.8 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$30.8 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$26.7 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$15.4 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.06B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account